Clinical Trials Directory

Trials / Completed

CompletedNCT03178396

Effects and Mechanisms of Melatonin on Blood Pressure, Insulin Resistance, and Platelets

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Thomas Jefferson University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The investigators will be studying the effect of melatonin on blood pressure, insulin resistance, and platelets, along with possible reasons for how melatonin cases these effects.

Detailed description

The investigators will be studying the effect of melatonin on blood pressure and insulin resistance, and possible reasons for how melatonin works on blood pressure and IR. Along with blood testing to measure adipokines, insulin resistance (IR), and platelet function (how well your blood clots), 24-hour ambulatory blood pressure monitoring (ABPM) will be used to measure blood pressure, since ABPM is the gold standard (best method) for accurate assessment of blood pressure status and associated cardiovascular risk. Vascular (blood vessel) function, IR, adipokine levels and sleep quality will also be measured. All study endpoints will be measured at baseline and following 6 weeks of daily melatonin 9 mg dosing.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmelatonincontrolled release, 9 mg taken 30 minutes before bedtime x 6 weeks

Timeline

Start date
2015-12-07
Primary completion
2016-08-09
Completion
2016-08-09
First posted
2017-06-06
Last updated
2017-06-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03178396. Inclusion in this directory is not an endorsement.